Melanoma Cells Exposed to Clomiphene Citrate Respond With Cell Cycle Arrest and Reduced Invasiveness
Journal of Applied Toxicology · 2026
DOI: 10.1002/jat.70198 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Toxicology, 2026. Verfasst von Thaís S Ribeiro und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Pathology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil. Hauptthemen laut MEDLINE: Melanoma, Clomiphene, Cell Cycle Checkpoints. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG).
Abstract (Originalsprache)
Epidemiological studies have suggested that clomiphene citrate (CC) exposure may increase the risk of malignant melanoma, but mechanisms are unknown. We investigated the effects of CC on melanoma cell line A375. Cells were treated with CC at 2, 20, 200, and 2000 ng/mL, followed by assessment of cell viability and metabolism, cell cycle, migration, and expression of genes associated with epithelial–mesenchymal transition and mitochondrial oxidative stress. At 48 h, 2000‐ng/mL CC reduced cell viability by 80% ( p < 0.0001), induced early G1‐phase arrest ( p < 0.0001), and impaired cell migration. Gene expression analysis revealed decreased N‐cadherin/ CDH2 ( p < 0.05) and SOD2 ( p < 0.01) gene expression in the presence of CC, suggesting antimetastatic and prooxidant effects. These results indicate that direct exposure to CC does not promote aggressive melanoma cell behavior in vitro.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Pathology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil.
- Department of Obstetrics and Gynecology, Federal University of Minas Gerais, Belo Horizonte, Brazil.
ORCID-Profile: Pedro H D M Prazeres, Helen L Del Puerto
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG)
Zitieren
APA
Ribeiro, T. S., Silva, F. H. S., Miranda, A. P. G. S., Borges, I. T., Prazeres, P. H. D. M., Ferreira, M. C. F., Ferreira, E., Reis, F. M., & Del Puerto, H. L. (2026). Melanoma Cells Exposed to Clomiphene Citrate Respond With Cell Cycle Arrest and Reduced Invasiveness. Journal of Applied Toxicology. https://doi.org/10.1002/jat.70198
Vancouver
Ribeiro TS, Silva FHS, Miranda APGS, Borges IT, Prazeres PHDM, Ferreira MCF, et al. Melanoma Cells Exposed to Clomiphene Citrate Respond With Cell Cycle Arrest and Reduced Invasiveness. Journal of Applied Toxicology. 2026. doi:10.1002/jat.70198
BibTeX
@article{Ribeiro2026,
author = {Ribeiro, Thaís S and Silva, Felipe H S and Miranda, Ana Paula G S and Borges, Isabella T and Prazeres, Pedro H D M and Ferreira, Marcia C F and Ferreira, Enio and Reis, Fernando M and Del Puerto, Helen L},
title = {Melanoma Cells Exposed to Clomiphene Citrate Respond With Cell Cycle Arrest and Reduced Invasiveness},
journal = {Journal of Applied Toxicology},
year = {2026},
doi = {10.1002/jat.70198}
}
EUVIMED